Right over left ventricular end-diastolic area relevance to predict hemodynamic intolerance of high-frequency oscillatory ventilation in patients with severe ARDS
- PMID: 26380993
- PMCID: PMC4573736
- DOI: 10.1186/s13613-015-0068-6
Right over left ventricular end-diastolic area relevance to predict hemodynamic intolerance of high-frequency oscillatory ventilation in patients with severe ARDS
Abstract
Background: High-frequency oscillatory ventilation (HFOV) does not improve the prognosis of ARDS patients despite an improvement in oxygenation. This paradox may partly be explained by HFOV hemodynamic side-effects on right ventricular function. Our goal was to study the link between HFOV and hemodynamic effects and to test if the pre-HFOV right over left ventricular end-diastolic area (RVEDA/LVEDA) ratio, as a simple parameter of afterload-related RV dysfunction, could be used to predict HFOV hemodynamic intolerance in patients with severe ARDS.
Methods: Twenty-four patients were studied just before and within 3 h of HFOV using transthoracic echocardiography and transpulmonary thermodilution.
Results: Before HFOV, the mean PaO2/FiO2 ratio was 89 ± 23. The number of patients with a RVEDA/LVEDA ratio >0.6 significantly increased after HFOV [11 (46 %) vs. 17 (71 %)]. Although HFOV did not significantly decrease the arterial pressure (systolic, diastolic, mean and pulse pressure), it significantly decreased the cardiac index (CI) by 13 ± 18 % and significantly increased the RVEDA/LVEDA ratio by 14 ± 11 %. A significant correlation was observed between pre-HFOV RVEDA/LVEDA ratio and CI diminution after HFOV (r = 0.78; p < 0.0001). A RVEDA/LVEDA ratio superior to 0.6 resulted in a CI decrease >15 % during HFOV with a sensitivity of 80 % (95 % confidence interval 44-98 %) and a specificity of 79 % (confidence interval 49-95 %).
Conclusion: The RVEDA/LVEDA ratio measured just before HFOV predicts the hemodynamic intolerance of this technique in patients with severe ARDS. A high ratio under CMV raises questions about the use of HFOV in such patients.
Trial registration: ClinicalTrials.gov: NCT01167621.
Keywords: Acute respiratory distress syndrome; Acute right ventricular dysfunction; Echocardiography; Hemodynamic monitoring; High-frequency oscillatory ventilation; Transpulmonary thermodilution.
Figures


References
-
- Niwa T, Hasegawa R, Ryuge M, Kawase M, Kondoh Y, Taniguchi H. Benefits and risks associated with the R100 high frequency oscillatory ventilator for patients with severe hypoxaemic respiratory failure. Anaesth Intensive Care. 2011;39:1111–1119. - PubMed
-
- Adhikari NKJ, Bashir A, Lamontagne F, Mehta S, Ferguson ND, Zhou Q, et al. High-frequency oscillation in adults: a utilization review. Crit Care Med. 2011;39:2631–2644. - PubMed
Associated data
LinkOut - more resources
Full Text Sources
Other Literature Sources